STOCK TITAN

Jeffrey P. Somers of DHC (DHC) awarded 12,401 common shares in equity grant

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

SOMERS JEFFREY P. reported acquisition or exercise transactions in this Form 4 filing.

Diversified Healthcare Trust director Jeffrey P. Somers received an award of 12,401 Common Shares of Beneficial Interest on June 10, 2026 under the company’s equity compensation plan. The grant was at a stated price of $0.00 per share, bringing his direct holdings to 177,079 shares.

Positive

  • None.

Negative

  • None.
Insider SOMERS JEFFREY P.
Role null
Type Security Shares Price Value
Grant/Award Common Shares of Beneficial Interest 12,401 $0.00 --
Holdings After Transaction: Common Shares of Beneficial Interest — 177,079 shares (Direct, null)
Footnotes (1)
  1. [object Object]
Equity award shares 12,401 shares Common Shares of Beneficial Interest granted June 10, 2026
Award price per share $0.00 per share Reported transaction price for equity grant
Shares held after grant 177,079 shares Total direct holdings following transaction
Common Shares of Beneficial Interest financial
"security_title: "Common Shares of Beneficial Interest""
Common Shares of Beneficial Interest are units that represent ownership in a company or organization, like owning a piece of a pie. They give investors voting rights and a chance to share in profits, making them important for those looking to invest and have a say in how the organization is run.
equity compensation plan financial
"award of shares pursuant to the Issuer's equity compensation plan"
A plan by which a company gives employees, directors or contractors ownership or the right to buy ownership in the company through stock, options or similar awards — think of promising slices of the company pie as part of someone's pay. It matters to investors because these awards can change the number of shares outstanding, affect reported profits and influence management’s decisions; large or generous plans can dilute existing holders and alter incentives over time.
Grant, award, or other acquisition financial
"transaction_code_description: "Grant, award, or other acquisition""
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transaction did DHC director Jeffrey P. Somers report on this Form 4?

Jeffrey P. Somers reported receiving an award of 12,401 Common Shares of Beneficial Interest. The shares were granted on June 10, 2026, as part of Diversified Healthcare Trust’s equity compensation plan and were recorded at a stated price of $0.00 per share.

How many DHC shares does Jeffrey P. Somers hold after this equity award?

After the June 10, 2026 award, Jeffrey P. Somers directly holds 177,079 Common Shares of Beneficial Interest in Diversified Healthcare Trust. This total includes the 12,401 shares granted under the issuer’s equity compensation plan as reported in the Form 4 filing.

What was the price per share for the DHC equity award granted to Jeffrey P. Somers?

The 12,401 Common Shares of Beneficial Interest granted to Jeffrey P. Somers were reported at a transaction price of $0.00 per share. This indicates a compensatory equity grant under Diversified Healthcare Trust’s equity compensation plan rather than an open-market purchase transaction.

Was the DHC insider transaction for Jeffrey P. Somers a purchase or an equity grant?

The transaction was an equity grant, not a market purchase. The Form 4 classifies it under code A, described as a grant, award, or other acquisition, with 12,401 shares awarded pursuant to Diversified Healthcare Trust’s equity compensation plan at a stated price of $0.00 per share.

Does the Form 4 for DHC indicate any derivative securities or option exercises for Jeffrey P. Somers?

The filing does not report any derivative securities or option exercises for Jeffrey P. Somers. It shows a single non-derivative transaction: an award of 12,401 Common Shares of Beneficial Interest under Diversified Healthcare Trust’s equity compensation plan, with no derivative positions listed afterward.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
SOMERS JEFFREY P.

(Last)(First)(Middle)
C/O THE RMR GROUP LLC
TWO NEWTON PL., 255 WASH. ST., STE. 300

(Street)
NEWTON MASSACHUSETTS 02458

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
DIVERSIFIED HEALTHCARE TRUST [ NASDAQ:DHC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/10/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Shares of Beneficial Interest06/10/2026A12,401A(1)177,079D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Transaction reported is award of shares pursuant to the Issuer's equity compensation plan.
/s/ Jeffrey P. Somers06/12/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)